Personalizing Health
search
Home
Corporate
Medical
Overview
Breast & Ovarian Cancer
Bowel & Uterine Cancer
Neurogenetics
Epilepsy
Forensics
Overview
Presumptive & Confirmatory Testing
Individual DNA Profiling
Species Identification
Animal Forensic Testing
Paternity
Legal - Paternity
Non Legal - Paternity
Legal Practitioners
Antenatal
Deceased Estate
DNA In A Day
Sibship
Twins
Y – Chromosome
DNA Profiling
Grandparent
Immigration
Personal
Overview
Sports Performance
Ancestry
Animals
DNA Testing
BITSA
Animal Forensics
Plants
Genomic Services
Xpress Sequencing
Announcements
Cleansing notice
Cleansing notice - 27 July 2011
Completion of Successful Capital Raising
Completion of Successful Capital Raising
Response to Price and Volume Query
Response to Price and Volume Query
Market Update
Market Update
Genetic Technologies Executes Settlement and License Agreement with Navigenics Inc.
Genetic Technologies Executes Settlement and License Agreement with Navigenics Inc.
Previous Announcements
Launch of BREVAGen test in US
SERL substantial shareholder notice - 6 June 2011
US Investor Presentation - June 2011
GTG GENE processes first BREVAGen sample
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 8 of 30
Announcements
Settlement with GeneSeek
Appendix 3B - 20 April 2012
Forfeiture of options - 19 April 2012
Latest News
GENE: 1H12 Earnings Preview
GTG Oct-Dec 2011 4C Commentary
Biotech Daily - The Year in Review - CEO Of The Year Dr Paul MacLeman
Share Price
